Pandora, Gap Post R...
Health Care: Drugs
Lexicon Pharmaceuticals Inc. (LXRX: NASDAQ)
$2.19 0.06 | 2.82%
05/23/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 1.09M | 1.85M | 4.91M | 10.70M |
| Cost of Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Operating Profit | 1.09M | 1.85M | 4.91M | 10.70M |
| Selling, General, and Administrative Expenses | 17.04M | 17.35M | 22.57M | 19.42M |
| Research & Development | 82.57M | 91.83M | 75.35M | 81.24M |
| Operating Income before D & A (EBITDA) | -98.53M | -107.33M | -93.01M | -89.96M |
| Depreciation & Amortization | 4.19M | 4.89M | 9.35M | 8.30M |
| Interest Income | 213.00K | 255.00K | 519.00K | 880.00K |
| Other Income - Net | -9.78M | -6.61M | -6.59M | -1.38M |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -112.29M | -118.57M | -108.43M | -98.75M |
| Interest Expense | 2.11M | 2.53M | 2.72M | 2.97M |
| Pre-Tax Income | -114.40M | -121.10M | -111.15M | -101.72M |
| Income Taxes | 0.00 | 0.00 | -26.00K | -102.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | -10.54M |
| Net Income From Continuing Operations | -110.21M | 0.00 | 0.00 | 0.00 |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -110.21M | 0.00 | 0.00 | 0.00 |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -110.21M | -116.22M | -101.78M | -82.78M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-110.21M | 0.00 | 0.00 | 0.00 |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -110.21M | 0.00 | 0.00 | 0.00 |
| Basic EPS from Continuing Ops. | -0.23 | -0.34 | -0.34 | -0.57 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.23 | -0.34 | -0.34 | -0.57 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.23 | -0.34 | -0.34 | -0.57 |
| Basic Normalized Net Income/Share | -0.23 | n.a. | n.a. | n.a. |
| EPS fr Continuing Ops. | -0.23 | -0.34 | -0.34 | -0.57 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.23 | -0.34 | -0.34 | -0.57 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.23 | -0.34 | -0.34 | -0.57 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.23 | n.a. | n.a. | n.a. |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with LXRX
- Portfolio NameUser Type
- UserMy stocks
- ContributorStocks With Big Insider Buy...
- UserMy SP portfolio
- UserWatch
- ContributorStocks Under-$10 Setting Up...
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks Under-$10 Moving Hig...
- Contributor8 Health Care Stocks With R...
- Userhpats Portfolio 1
- Userpkc89
Latest LXRX Headlines from TheStreet
- Lexicon Pharma Falls on Concerns Raised by Merck-Pfizer Diabetes Partnership 04.29.13 | 11:04 am
- 8 Stocks Under $5 Seeing Institutional And Insider Buying 04.02.13 | 03:04 pm
- 7 Biotechnology Stocks With Insider Buying Activity 03.20.13 | 10:03 am
- 10 Stocks Insiders And Hedge Funds Think Will Go Higher 03.11.13 | 01:03 pm
- Still Bullish on BioMarin, Lexicon Pharma 11.07.12 | 11:11 am
- 5 Stocks Insiders Love Right Now 10.31.12 | 02:10 pm
- Lexicon Pharma: Blockbuster Potential From A Diabetes Drug 10.16.12 | 06:10 am
- Lexicon Pharmaceuticals' CEO Presents At Morgan Stanley Healthcare Conference (Transcript) 09.11.12 | 02:09 pm
- Lexicon's CEO Presents At Wedbush PacGrow 2012 Life Sciences Management Access Conference (Transcript) 08.14.12 | 05:08 pm
- Lexicon Pharmaceutical's CEO Discusses Q2 2012 Results - Earnings Call Transcript 07.31.12 | 02:07 pm
Press Releases for LXRX
- Lexicon To Present At The Bank Of America Merrill Lynch Healthcare Conference - PR Newswire 05.13.13 | 06:05 am
- Lexicon Advances LX4211 In Type 1 Diabetes Phase 2 Trial - PR Newswire 05.10.13 | 06:05 am
- Lexicon To Report First Quarter Financial Results On May 10, 2013 - PR Newswire 05.03.13 | 06:05 am
- Lexicon To Present At The Needham Healthcare Conference - PR Newswire 04.25.13 | 06:04 am
- Lexicon To Present At The Cowen Healthcare Conference - PR Newswire 03.01.13 | 06:03 am
- Lexicon To Present At The RBC Capital Markets Healthcare Conference - PR Newswire 02.25.13 | 06:02 am
- Lexicon To Report Fourth Quarter And Year End 2012 Financial Results On February 21, 2013 - PR Newswire 02.18.13 | 06:02 am
- Lexicon To Present At The BIO CEO & Investor Conference - PR Newswire 02.06.13 | 06:02 am
- Lexicon To Present At The J.P. Morgan Healthcare Conference - PR Newswire 01.03.13 | 06:01 am
- Lexicon's Drug Candidate For Irritable Bowel Syndrome Receives Fast Track Status From The FDA - PR Newswire 12.17.12 | 06:12 am
Partner Headlines for LXRX
- Investors Wait On Developments For Lexicon Pharmaceuticals - Seeking Alpha 01.03.13 | 08:01 am
- Three Compelling Biopharma Stocks For 2013 - Seeking Alpha 12.26.12 | 09:12 am
- Top 5 Stocks With Insider Buys Filed During The Week Ending October 26 - Seeking Alpha 10.28.12 | 07:10 am
- Lexicon Prices 17.5M Shares At $2.25 per Share - Benzinga 10.18.12 | 09:10 am
- Will Lexicon Pharmaceuticals's Top Institutional Shareholders DOUBLE DOWN on These Hot Catalysts? - Wall St. Cheat Sheet 06.29.12 | 12:06 pm
- Healthcare Biz Review: Icahn SUES Forest, eHealth's EXCELLENT News - Wall St. Cheat Sheet 06.29.12 | 09:06 am
- Comcast's OLYMPIC Strategy and 4 Buzzing Stocks to Know Friday - Wall St. Cheat Sheet 06.29.12 | 09:06 am
- Apollo Group SPIKES 10% to Lead These 5 NASDAQ Top Percentage Winners - Wall St. Cheat Sheet 06.27.12 | 10:06 am
- Wall St. Watchdog Stock Analysts Reiterated Their Ratings of These 3 Shares Today - Wall St. Cheat Sheet 06.26.12 | 03:06 am
- Lexicon UPBEAT Regarding Drug Trial and 4 HOT Analyst Alerts - Wall St. Cheat Sheet 06.26.12 | 02:06 am
